Polyrizon Ltd. PLRZ
PLRZ
Polyrizon Ltd. CYCN
Cyclerion Therapeutics, Inc. XTLB
XTL Biopharmaceuticals Ltd. TCRT
Alaunos Therapeutics, Inc. KTTA
Pasithea Therapeutics Corp. QNRX
Quoin Pharmaceuticals, Ltd. VYNE
VYNE Therapeutics Inc. RADX
Radiopharm Theranostics Limited PMCB
PharmaCyte Biotech, Inc. NBY
NovaBay Pharmaceuticals, Inc.
Polyrizon Ltd. CYCN
Cyclerion Therapeutics, Inc. XTLB
XTL Biopharmaceuticals Ltd. TCRT
Alaunos Therapeutics, Inc. KTTA
Pasithea Therapeutics Corp. QNRX
Quoin Pharmaceuticals, Ltd. VYNE
VYNE Therapeutics Inc. RADX
Radiopharm Theranostics Limited PMCB
PharmaCyte Biotech, Inc. NBY
NovaBay Pharmaceuticals, Inc.
Performance
| Periode | PLRZ | CYCN | XTLB | TCRT | KTTA | QNRX | VYNE | RADX | PMCB | NBY |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 110.30 % | -51.19 % | -12.68 % | -15.86 % | 50.40 % | 61.74 % | -36.40 % | 17.66 % | -17.45 % | 789.49 % |
| YTD | -99.67 % | -56.23 % | -57.87 % | 83.23 % | -61.60 % | -40.17 % | -83.00 % | 14.36 % | -46.65 % | 704.78 % |
| 1Y | -99.74 % | -51.19 % | -43.15 % | 78.70 % | -57.87 % | -37.87 % | -76.32 % | 18.98 % | -46.65 % | 914.02 % |
| 3Y | -99.60 % | -88.20 % | -38.52 % | -95.58 % | -92.50 % | -97.71 % | -80.94 % | -69.97 % | -69.72 % | -89.94 % |
| 5Y | -99.60 % | -97.79 % | -70.67 % | -99.14 % | -98.42 % | -99.97 % | -99.58 % | -69.97 % | -88.71 % | -99.34 % |
| 10Y | -99.60 % | -99.42 % | -89.75 % | -99.71 % | -98.42 % | -100.00 % | -99.97 % | -69.97 % | -99.15 % | -99.88 % |
| Depuis le début | -99.60 % | -99.42 % | -99.85 % | -99.85 % | -98.42 % | -100.00 % | -99.97 % | -69.97 % | -98.47 % | -100.00 % |